Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04517318
NCT04517318
Completed
Not Applicable

A Multi-center Study of the Treatment Patterns and Clinical Outcomes of Subsequent Therapies After Progression on Palbociclib in HR+/HER2- Metastatic Breast Cancer

Fudan University1 site in 1 country200 target enrollmentAugust 15, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Fudan University
Enrollment
200
Locations
1
Primary Endpoint
PFS
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

To evaluate the prescription patterns and treatment outcomes of subsequent therapies after progression on palbociclib in the real world.

Registry
clinicaltrials.gov
Start Date
August 15, 2017
End Date
July 15, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Biyun Wang, MD

Professor

Fudan University

Eligibility Criteria

Inclusion Criteria

  • •woman, age \> 18 years old
  • •Diagnosed with HR+/HER2- Metastatic Breast Cancer
  • •Patients received at least one-cycle next-line treatment after progression on combined palbociclib and endocrine therapy
  • •Complete medical history was available

Exclusion Criteria

  • •Medical history was incomplete

Outcomes

Primary Outcomes

PFS

Time Frame: 6 weeks

Progression free survival

Adverse events

Time Frame: 6 weeks

Number of participants with treatment-related adverse events as assessed by Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v4.0)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System TuberculosisCentral Nervous System Tuberculosis
NCT06011915Tongji Hospital638
Active, not recruiting
Not Applicable
A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis PatientsTuberculosis
NCT06021041Tongji Hospital900
Completed
Not Applicable
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in BelgiumCarcinoma, Non-Small-Cell Lung
NCT03761901AstraZeneca141
Completed
Not Applicable
Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:Lung Cancer
NCT04836975AstraZeneca45
Completed
Not Applicable
An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)Breast Cancer
NCT01615068Genentech, Inc.1,007